Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DICE Chemotherapy in NK/T Cell Lymphoma
NCT00568607Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Mar 2007
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, etoposide, cisplatin, dexamethasone in Natural killer T-cell lymphoma (NKTL), sponsored by Fudan University. Status: unknown.
02
Drugs
ifosfamideetoposidecisplatindexamethasone
03
Conditions
Natural killer T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on NCT00568607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568607.